Structural heart disease articles

8va edicion curso José Gabay

The 8th edition of ProEducar course José Gabay for interventionists in training has started

The 8th edition of ProEducar course José Gabay for interventionists in training has started

A new edition of ProEducar José Gabay course started at Pacará Room, at Buenos AIres Hilton Hotel. In a friendly, warm atmosphere, the Fellowship Director, Dr. Leandro Lasave, set opened the course together with SOLACI-CACI 2017 President, Dr. Ruben Piraino, and CACI vice President, Dr Anibal Damonte.  Dr. Lasave thanked both SOLACI and CACI authorities

Lotus vs Sapien 3, mecanismos diferentes con resultados similares

Lotus vs Sapien 3, different mechanisms with similar results

The new generation devices for transfemoral transcatheter aortic valve replacement have been optimized to improve valve position and reduce residual aortic regurgitation.   This study compared 30 day, 12 month and 24 month outcomes of the repositionable, Lotus valve, with controlled mechanical expansion, and the balloon-expandable valve Edwards Sapien 3.   Primary end point was all cause mortality

¿Cómo clasificar la estenosis aórtica de los pacientes que recibieron TAVI?

How can we classify aortic stenosis in patients who underwent TAVR?

Courtesy of Dr. Carlos Fava. Aortic stenosis can present different hemodynamic patterns, such as low flow and low gradient with reduced or preserved ventricular function. However, evidence on the evolution of different hemodynamic patterns after transcatheter aortic valve replacement (TAVR) is limited. This study consisted in a retrospective analysis of 368 patients who underwent TAVR. The population was divided in

El aumento de la experiencia de los operadores mejora los resultados en el TAVI

Increasing operator experience improves TAVR outcomes

The introduction of transcatheter aortic valve replacement (TAVR) into clinical practice in the United States has been a tightly controlled process aimed at optimizing patient outcomes and minimizing the learning curve. Many strategies have been used to reach a rational dispersion for this new technology, including choosing sites with enough volume, and adequate operator training

Desempeño de la válvula Lotus en relación al implante de marcapaso en pacientes Post-TAVI

Lotus Valve performance related to pacemaker implantation in patients after TAVR

Courtesy of Dr. Agustín Vecchia. Paravalvular leak was once considered the greatest disadvantage of TAVR when compared to conventional surgery. Nowadays, new devices and more-experienced operators have managed to “control” this phenomenon, keeping related statistics within acceptable ranges. Repositionable-valve Lotus may probably offer the most effective solution for this event; however, it is associated with high rates of

MitraClip: ¿debemos intervenir antes a nuestros pacientes?

MitraClip: Should We Intervene Earlier?

Courtesy of Dr. Carlos Fava. Repairing the mitral valve with Mitraclip has become an alternative for high risk or inoperable symptomatic patients, but its long term evolution has only been tested by the EVEREST II, which had not taken into account 5 year mortality outcomes. Therefore, to better study its evolution, we need to carry out different randomized studies

NOTION: TAVI with Low Risk at 4 Year Follow Up

Post-dilation in TAVI associated to more stroke and more paravalvular regurgitation

Courtesy of Dr. Carlos Fava. Moderate/severe paravalvular regurgitation (PVR) after TAVR is present in 10%-14% of all cases, according to different series. The treatment of choice is post-dilation, generally effective in most cases. However, this strategy carries a risk of stroke. The true impact of this conduct is still unclear.   This review analyzed 6 studies that included 5007 patients; 889 of

El reemplazo transcatéter en válvulas bicúspides suma evidencia pero continúan los desafíos

Transcatheter valve replacement in the bicuspid valve is increasingly performed, but challenges remain

As experience increases, transcatheter aortic valve replacement (TAVR) has expanded to different populations and anatomies. This study sought to compare technical and clinical outcomes in patients with bicuspid versus tricuspid aortic stenosis from the Bicuspid AS TAVR Multicenter Registry.   Outcomes of 561 patients with bicuspid valves and 4546 patients with tricuspid valves were compared. Propensity score matching was used

Incidencia, características y tratamiento de la trombosis valvular post TAVI

Incidence, characteristics, and treatment of valve thrombosis after TAVR

Certain studies have carried out a tomographic follow-up of patients who underwent transcatheter aortic valve replacement (TAVR) and described the frequency of leaflet thrombosis; however, in most cases, it is unclear whether this finding requires some sort of intervention. The difference between this work and those previously published is that this study is not focused on imaging, it

Evolución de pacientes jóvenes con miocardiopatía hipertrófica tratados con ablación septal por alcoholización.

Progress of patients with hypertrophic cardiomyopathy treated with alcohol septal ablation

Courtesy of Dr. José Álvarez. Alcohol septal ablation (ASA) for the treatment of obstructive hypertrophic cardiomyopathy (OHC) is a procedure introduced in 1995 as an alternative to surgical myectomy.   The American College of Cardiology (ACC)/American Heart Association (AHA) guidelines indicate that ASA should be reserved for older patients with comorbidities, thus establishing surgical myectomy

Predilatación en TAVI ¿Datos definitivos para no complicarse tomando decisiones?

TAVI without predilation is feasible and safe

Courtesy of Dr. Carlos Fava. Transcatheter aortic valve implantation has already proven to be beneficial for high-risk and inoperable patients. In that sense, it is also an increasingly frequent solid option for lower-risk patients. However, due to the presence of valve calcifications, it may occasionally be necessary to assess the benefits and risks of valve dilation

Top